Grants per year
Grants
- 2 Active
Search results
-
Active
Prot #MKC‐TI‐193: INHALE‐3: A 17‐Week Randomized Trial and a 13‐Week Extension, Evaluating theEfficacy and Safety of Inhaled Insulin (Afrezza®) Combined with Insulin Degludec Versus Usual Care in Adults with Type 1 Diabetes
Aleppo, G. (PD/PI), Coyne, K. J. (Co-Investigator) & Kravarusic, J. (Co-Investigator)
Jaeb Center for Health Research, MannKind Corporation
7/28/23 → 7/28/26
Project: Research project